Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

US Patent 12453780 · Granted Oct 28, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
ADAM17 binding molecules and uses thereof2025
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy2025
Compositions and methods for treating cancer with DuoCARs2025
Method to treat cancer with engineered T-cells2025
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy2024
Compositions and methods for treating cancer with anti-CD123 immunotherapy2024
Compositions and methods for treating cancer with anti-CD123 immunotherapy2024
Human monoclonal antibodies against EphA4 and their use2024
Compositions and methods for treating HIV/AIDS with immunotherapy2024
Methods of treatments using antigen-binding proteins targeting CD562024